[1] Eguchi H, Tsuruta M, Tani J, et al. Hypophosphatemic osteomalacia due to drug-induced Fanconi’s syndrome associated with adefovir dipivoxil treatment for hepatitis B. Intern Med, 2014, 53: 233-237.
[2] Terasaka T, Ueta E, Ebara H, et al. Long-term observation of osteomalacia caused by adefovir-induced Fanconi’s syndrome. Acta Med Okayama, 2014, 68:53-56.
[3] Jeong HJ, Lee JM, Lee TH, et al. Two cases of hypophosphatemic osteomalacia after long-term low dose adefovir therapy in chronic hepatitis B and literature review. J Bone Metab, 2014, 21: 76-83.
[4] 邹羽真,胡扬,张波.阿德福韦酯致范可尼综合征 1 例及 41 例不良反应报道汇总分析.临床药物治疗杂志,2015,13:68-73.
[5] 张帅,房舒舒,曹国颖.阿德福韦酯治疗乙肝致低磷血症及骨软化症文献汇总及数据分析.中国新药杂志,2015,24:1795-1800.
[6] 邹羽真,胡扬,张波.阿德福韦酯致范可尼综合征 1 例及 41 例不良反应报道汇总分析.临床药物治疗杂志,2015,13:68-73.
[7] 张帅,房舒舒,曹国颖.阿德福韦酯治疗乙肝致低磷血症及骨软化症文献汇总及数据分析.中国新药杂志,2015,24:1795-1800. |
